1492 Capital Management »

Pelthos Therapeutics shares owned by 1492 Capital Management

Quarter-by-quarter ownership of Pelthos Therapeutics (PTHS) shares owned by 1492 Capital Management from 13F filings

Historical chart of 1492 Capital Management investment in Pelthos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pelthos Therapeutics held by 1492 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pelthos Therapeutics by 1492 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $293k 10k 28.26

More positions owned by 1492 Capital Management

MaxLinear (MXL)
Carpenter Technology Corporation (CRS)
Alignment Healthcare (ALHC)
Applied Optoelectronics (AAOI)
Sterling Construction Company (STRL)
Copa Holdings Sa Cl A (CPA)
Adaptive Biotechnologies Cor (ADPT)
Allegheny Technologies Incorporated (ATI)
Adtran Holdings (ADTN)
Kaiser Aluminium Corporation Com Par $0.01 (KALU)
Lumentum Hldgs (LITE)
Zeta Global Holdings Corp Cl A (ZETA)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Axsome Therapeutics (AXSM)
Meritage Homes Corporation (MTH)

View all positions for 1492 Capital Management

Top funds holding Pelthos Therapeutics

AIGH Capital Management
Murchinson
Ikarian Capital
Boothbay Fund Management
Vanguard Capital Management
Cantor Fitzgerald, L. P.
J. Goldman & Co
Diadema Partners
Wexford Capital
Knott David M Jr
Citadel Advisors
Geode Capital Management
Pale Fire Capital SE
1492 Capital Management
Vanguard Fiduciary Trust

View all funds holding Pelthos Therapeutics